Debate between brand and generic drug companies contues to rage over whether the Waxman-Hatch Act should be overhauled.
Finish The Fight: Patients Can Push PBM Reform Legislation Over the Finish Line | NCPA 2024
PBM reform legislation has progressed further in Congress than ever before.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
Senators Call on FTC to Investigate PBM Co-Manufacturing Tactic
Senators Ron Wyden and Sherrod Brown wrote a letter to the Federal Trade Commission calling to explore yet another PBM tactic impeding competition.
Keep Up With Policy Changes Affecting Independent Pharmacy
This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.
How the Big 3 PBMs Utilize Various Market Strategies
To further understand PBM market concentration, researchers separately analyzed commercial insurance, Medicare Part D, and Medicaid managed care market strategies of the 3 biggest PBMs.
Q&A: As Scope of Practice Expands, Technology Must Catch Up
Pharmacists can fill a role for patients, but without technology supporting workflows and reimbursement efforts, challenges will remain.